Medical expert of the article
New publications
Tuberculous pleurisy
Last reviewed: 04.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Tuberculous pleurisy is an acute, subacute, chronic or recurrent tuberculous inflammation of the pleura that can occur as a complication of any form of tuberculosis.
Most often, pleurisy is observed in pulmonary tuberculosis. Occasionally, it can occur as an independent clinical form, i.e. without clearly defined tuberculous lesions of other organs, and be the first clinical manifestation of tuberculous infection in the body.
Epidemiology of tuberculous pleurisy
In Ukraine and Russia, tuberculosis etiology is noted in almost half of all patients with exudative pleurisy. In newly diagnosed patients with tuberculosis of the respiratory organs, tuberculous pleurisy is diagnosed in 3-6% of cases, more often in children, adolescents, and young people. In the structure of causes of death from tuberculosis, pleurisy is about 1-2%, and mainly it is chronic purulent pleurisy.
Pathogenesis and pathological anatomy of tuberculous pleurisy
Pleurisy often complicates the course of tuberculosis of the intrathoracic lymph nodes, primary complex, disseminated tuberculosis. In the pathogenesis of pleurisy, great importance is attached to preliminary specific sensitization of the pleura, as an important condition for the development of inflammation under the influence of mycobacteria. A close anatomical and functional relationship between the lymphatic system of the lungs and the pleura plays a significant role in the pathogenesis of tuberculous pleurisy.
Tuberculous pleurisy can be allergic (paraspecific), perifocal and occur in the form of pleural tuberculosis. Depending on the nature of the pleural contents, tuberculous pleurisy can be dry (fibrinous) and exudative. Purulent exudative pleurisy is called tuberculous empyema of the pleura.
Allergic pleurisy occurs as a result of a hyperergic exudative reaction of the pleural sheets to tuberculous infection. Such a reaction is observed mainly in primary tuberculosis, which is characterized by high sensitization of many tissues, including serous membranes. Abundant serous or serous-fibrinous exudate is formed in the pleural cavity, fibrin deposits appear on the pleura. The cellular composition of the exudate is lymphocytic or eosinophilic. Specific tuberculous changes are not detected, or isolated tuberculous tubercles are found on the pleural sheets.
Perifocal pleurisy develops in cases of contact damage to the pleural sheets from subpleurally located sources of tuberculous inflammation in the lung. It is observed in patients with primary complex, disseminated, focal, infiltrative, cavernous tuberculosis. At first, the pleural damage is local, with fibrin loss, but then serous or serous-fibrinous exudate appears.
Pleural tuberculosis occurs in different ways: lymphogenous, hematogenous and contact. It can be the only manifestation of tuberculosis or be combined with other forms of the disease.
In case of lymphogenous or hematogenous infection, multiple tuberculous rashes appear on the pleural sheets, and serous-fibrinous exudate appears in the pleural cavity. In cases of progression of the process and disintegration of tuberculous granulomas, the effusion becomes hemorrhagic. During involution of the process, the effusion is absorbed, the pleural sheets thicken, the pleural cavity is partially or completely obliterated.
The contact route of development of pleural tuberculosis is observed with subpleural localization of tuberculous inflammation in the lung, which, as a rule, spreads to the pleural sheets. In most patients, pleural damage is limited to a local inflammatory reaction. Tuberculous rashes, fibrinous deposits, granulation tissue appear on the visceral pleura, and effusion may appear in the pleural cavity. With the organization of fibrin and granulation, adhesions are formed between the sheets of the visceral and parietal pleura. Less often, contact tuberculous pleural damage is accompanied by the formation of a large amount of serous or serous-fibrinous exudate with a predominantly lymphocytic composition. Resorption of the exudate ends with the formation of fibrous deposits on the pleura, especially pronounced in the pleural sinuses.
Another variant of the contact route of development of pleural tuberculosis is the direct entry of infection into the pleural cavity from the affected lung. It occurs in cases of disintegration of subpleural caseous masses or perforation of the pulmonary cavity into the pleural cavity. Caseous masses, the contents of the cavity and often air penetrate into the pleural cavity through the resulting opening. The pleural cavity becomes infected with mycobacteria, the lung partially or completely collapses, and acute tuberculous empyema develops. The condition in which pus and air are simultaneously found in the pleural cavity is called pyopneumothorax.
With persistent communication of the cavity with the pleural cavity, chronic tuberculous empyema with a bronchopleural fistula is formed. The sheets of the parietal and visceral pleura in chronic tuberculous empyema are sharply thickened, hyalinized, calcified. Their surface is covered with caseous-necrotic and fibrinous-purulent masses. Non-specific purulent flora usually joins the tuberculous infection. Amyloidosis of the internal organs is often detected in patients with chronic tuberculous empyema.
Treatment of tuberculous empyema of the pleura ends with the formation of extensive pleural adhesions (adhesions), obliteration of the pleural cavity and fibrous changes in the lung and chest wall.
Symptoms of tuberculous pleurisy
The clinical picture of tuberculous pleurisy is varied and closely related to the characteristics of tuberculous inflammation in the pleural cavity and lungs. In some patients, other manifestations of tuberculosis, especially primary (paraspecific reactions, specific bronchial lesions) are observed simultaneously with pleurisy.
Allergic pleurisy begins acutely. Patients complain of chest pain, shortness of breath, and fever. Blood tests typically show eosinophilia and increased ESR. Exudate is serous, with a large number of lymphocytes; mycobacteria cannot be detected. Videothoracoscopy may reveal hyperemia of the pleural sheets. Anti-tuberculosis chemotherapy in combination with anti-inflammatory and desensitizing agents usually leads to an improvement in the condition and recovery without gross residual changes in the pleural cavity.
Perifocal pleurisy begins gradually or subacutely with the appearance of chest pain, dry cough, unstable subfebrile body temperature, slight weakness. Patients often point to previous hypothermia and flu as factors provoking the development of the disease. Pain in the side increases with coughing, bending to the opposite side. Characteristic signs are limited mobility of the chest when breathing on the affected side and pleural friction noise. The noise persists for several days, and then disappears under the influence of treatment or even without it. Sensitivity to tuberculin in dry tuberculous pleurisy is high, especially in children. Percussion, if there is no significant lung damage, does not reveal changes. X-rays reveal local tuberculous lesions of the lungs, pleural compaction and pleural adhesions in the form of low-intensity darkening areas. Only CT can more clearly identify inflammatory and fibrous compaction of the pleural sheets.
As exudate accumulates in the pleural cavity, the pain gradually weakens, pleural friction rub disappears, and typical physical, echographic, and radiographic signs of exudative pleurisy appear. The exudate is serous with a predominance of lymphocytes and a high content of lysozyme. Mycobacteria are absent in the exudate. Videothoracoscopy reveals changes in the visceral pleura over the affected area of the lung: hyperemia, thickening, and fibrin films. The course of perifocal pleurisy is usually long-term, often recurrent.
Pleural tuberculosis with exudative pleurisy may manifest itself with a clinical picture of varying severity. Most patients experience symptoms of intoxication for 2-3 weeks. Then the body temperature rises to febrile values, dyspnea appears and gradually increases, and constant pressing pain in the side occurs. In the early period of the inflammatory process, before the pleural sheets are stratified by exudate, pleural friction noise is heard. It may be accompanied by fine-bubble wet and dry wheezing. As fluid accumulates in exudative pleurisy and pleural empyema, a classic clinical picture develops, the ore wall on the side of the pleurisy lags behind during breathing. In cases of large pleural effusion, the intercostal spaces are smoothed out. Characteristic physical symptoms include a shortened or dull percussion sound, weakening or absence of vocal fremitus and respiratory noises over the affected area. During the period of exudate resorption, when the pleural sheets begin to touch each other, pleural friction noise is often heard again.
The condition of patients is most severe with pleural empyema. Characteristic are high body temperature, shortness of breath, night sweats, severe weakness, weight loss. If the exudate is not removed from the pleural cavity, it can fill the entire hemithorax and cause displacement and compression of the mediastinal organs with the development of pulmonary heart failure. This situation serves as an indication for urgent removal of fluid from the pleural cavity.
Typical complications of tuberculous empyema of the pleura include the breakthrough of purulent exudate into the bronchus or through the intercostal space. When pleural contents break into the bronchus, the patient coughs up pus, sometimes in large quantities. There is always a risk of aspiration pneumonia. A pleurobronchial fistula may form later.
Where does it hurt?
What's bothering you?
Diagnosis of tuberculous pleurisy
Changes in hemogram parameters in pleurisy correspond to the severity of pleural inflammation. Before the exudate is absorbed, patients with tuberculous pleurisy constantly show an increase in ESR (from 50-60 mm/h in the acute period to 10-20 mm/h during absorption). In the early stage of serous or serous-fibrinous pleurisy, moderate leukocytosis, an increase in the number of band neutrophils, eosinopenia and lymphopenia are observed; in hemorrhagic pleurisy and pleural empyema, pronounced leukocytosis.
In cases of rapid accumulation and repeated removal of exudate, patients develop hypoproteinemia. Other types of metabolism may be disrupted.
X-ray and ultrasound examination are very informative in case of exudative pleurisy. As the exudate accumulates, transparency in the area of the costophrenic sinus disappears, and the shadow of the fluid is revealed above the diaphragm. As the volume of fluid increases in the vertical position of the patient, a picture of darkening of the lower parts of the lung field with a parabolic upper border, going from above, from the outside down and inward, typical for free exudate is detected. The shadow of the exudate is intense and homogeneous. With a significant volume of fluid, the mediastinal organs shift to the opposite side. Free pleural effusion can be detected by ultrasound and CT: the fluid is located in the posterior part of the chest cavity and has a typical semi-oval appearance. If there is air in the pleural cavity, which can penetrate into it through a bronchopleural fistula or accidentally during pleural puncture, the upper border of the fluid remains horizontal regardless of the position of the patient's body (pneumopleurisy, pyopneumothorax). Fluorescence can be seen during fluoroscopy when the patient moves. The degree of lung collapse and adhesion between the visceral and parietal pleura is clearly determined using CT.
When one or more fluid accumulations are delimited by pleural adhesions, encapsulated pleurisy is formed (apical, paracostal, paramediastinal, supradiaphragmatic, interlobar). In such cases, the shape of the shadow does not change when the body position changes. Patients with encapsulated pleurisy, as a rule, have already been treated for tuberculosis, and they have residual post-tuberculous changes in the lungs and pleural cavity.
A dye test is very informative for confirming the presence of a peribronchial fistula: after introducing 3-5 ml of methylene blue solution into the pleural cavity during a puncture, the sputum is colored. If the fistula is of a significant diameter, amphoric breathing can be heard during auscultation, and bronchoscopy shows the flow of pleural contents into one of the bronchi (with air bubbles in case of pneumopleurisy). An X-ray examination in the vertical position of the patient allows detecting a collapsed lung and a horizontal level of fluid in the pleural cavity. The fistula opening from the side of the pleural cavity can be detected during videothoracoscopy.
When pus breaks through the intercostal space, it can collect under the superficial layer of the chest wall muscles or in the subcutaneous tissue (Empyema necessitasis) or break through the skin to the outside, forming a pleurothoracic (pleurocutaneous) fistula. Sometimes two fistulas occur in succession: pleurobronchial and pleurothoracic.
Who to contact?
Treatment of tuberculous pleurisy
- Tuberculosis - Treatment
- Chemotherapy for tuberculosis
- Anti-tuberculosis drugs
- Surgical methods of treatment of tuberculosis
- Pathogenetic therapy of tuberculosis
- Immunotherapy in the treatment of tuberculosis
- Physical methods of treating tuberculosis
- Methods of extracorporeal hemocorrection in tuberculosis